FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386466751> ?p ?o ?g. }

• W4386466751 abstract "Lung cancer is the most common cause of cancer-related deaths worldwide. Non-small-cell lung cancer (NSCLC) represents the majority of lung cancer cases, and its standard treatment is primarily surgery. Nonetheless, this type of cancer exhibits an important rate of tumor recurrence. Immune checkpoint inhibitors (ICIs) have demonstrated significant survival benefits in many cancers, especially in early-stage NSCLC. This review considers the latest CheckMate816, IMpower010 and KEYNOTE-091 trials that led to US FDA approvals. The new wave of resectable NSCLC trial results are also summarized. Finally, the latest challenges for these treatment modalities, such as the choice between neoadjuvant and adjuvant use, the accurate identification of biomarkers and the presence of driver mutations such as EGFR, are discussed.This article explains new results from cancer trials. In fact, the US FDA approved new treatments because of these findings. We sum up how cancer drugs help immune cells kill lung tumors. Moreover, the most common type of these tumors is non-small-cell lung cancer, a group that responds well to these drugs. The article provides a brief review of 2023 results to help both patients and doctors. Finally, some significant debates are presented. Among these questions are the following: Is treatment better before or after surgery? Will mutations reduce drug benefit? How can we tell whether the drug will work? Who can take these medicines? Will new tech help doctors?" @default.
• W4386466751 created "2023-09-07" @default.
• W4386466751 creator A5003862157 @default.
• W4386466751 creator A5005356941 @default.
• W4386466751 creator A5026607615 @default.
• W4386466751 creator A5043187610 @default.
• W4386466751 creator A5071338393 @default.
• W4386466751 date "2023-09-06" @default.
• W4386466751 modified "2023-10-11" @default.
• W4386466751 title "Tackling the immunotherapy conundrum: advances and challenges for operable non-small-cell lung cancer treatment" @default.
• W4386466751 cites W2016789384 @default.
• W4386466751 cites W2100184048 @default.
• W4386466751 cites W2130865996 @default.
• W4386466751 cites W2148334703 @default.
• W4386466751 cites W2198093519 @default.
• W4386466751 cites W2228221433 @default.
• W4386466751 cites W2314452004 @default.
• W4386466751 cites W2400514548 @default.
• W4386466751 cites W2466033276 @default.
• W4386466751 cites W2538232731 @default.
• W4386466751 cites W2754606968 @default.
• W4386466751 cites W2777461561 @default.
• W4386466751 cites W2799320595 @default.
• W4386466751 cites W2886963239 @default.
• W4386466751 cites W2889653218 @default.
• W4386466751 cites W2894796660 @default.
• W4386466751 cites W2898096144 @default.
• W4386466751 cites W2905051664 @default.
• W4386466751 cites W2922107046 @default.
• W4386466751 cites W2950603908 @default.
• W4386466751 cites W3087210493 @default.
• W4386466751 cites W3091616850 @default.
• W4386466751 cites W3109124091 @default.
• W4386466751 cites W3120020820 @default.
• W4386466751 cites W3128646645 @default.
• W4386466751 cites W3135611798 @default.
• W4386466751 cites W3137318920 @default.
• W4386466751 cites W3138819319 @default.
• W4386466751 cites W3140565772 @default.
• W4386466751 cites W3170252920 @default.
• W4386466751 cites W3190476676 @default.
• W4386466751 cites W3199241644 @default.
• W4386466751 cites W3207297681 @default.
• W4386466751 cites W3217379511 @default.
• W4386466751 cites W4200147408 @default.
• W4386466751 cites W4206769087 @default.
• W4386466751 cites W4210773546 @default.
• W4386466751 cites W4213085451 @default.
• W4386466751 cites W4214512176 @default.
• W4386466751 cites W4224293395 @default.
• W4386466751 cites W4225140159 @default.
• W4386466751 cites W4226382697 @default.
• W4386466751 cites W4253076228 @default.
• W4386466751 cites W4280495239 @default.
• W4386466751 cites W4280554654 @default.
• W4386466751 cites W4280569356 @default.
• W4386466751 cites W4286293529 @default.
• W4386466751 cites W4296036096 @default.
• W4386466751 cites W4296502006 @default.
• W4386466751 cites W4296988837 @default.
• W4386466751 cites W4297973509 @default.
• W4386466751 cites W4308538130 @default.
• W4386466751 cites W4309183981 @default.
• W4386466751 cites W4310172244 @default.
• W4386466751 cites W4318049596 @default.
• W4386466751 cites W4320856362 @default.
• W4386466751 cites W4321789282 @default.
• W4386466751 cites W4322718735 @default.
• W4386466751 cites W4327568983 @default.
• W4386466751 cites W4362586968 @default.
• W4386466751 cites W4366696594 @default.
• W4386466751 cites W4367173137 @default.
• W4386466751 cites W4379209546 @default.
• W4386466751 cites W4379283108 @default.
• W4386466751 cites W4379662223 @default.
• W4386466751 cites W4379662250 @default.
• W4386466751 cites W4382363420 @default.
• W4386466751 doi "https://doi.org/10.2217/imt-2023-0128" @default.
• W4386466751 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37671552" @default.
• W4386466751 hasPublicationYear "2023" @default.
• W4386466751 type Work @default.
• W4386466751 citedByCount "1" @default.
• W4386466751 crossrefType "journal-article" @default.
• W4386466751 hasAuthorship W4386466751A5003862157 @default.
• W4386466751 hasAuthorship W4386466751A5005356941 @default.
• W4386466751 hasAuthorship W4386466751A5026607615 @default.
• W4386466751 hasAuthorship W4386466751A5043187610 @default.
• W4386466751 hasAuthorship W4386466751A5071338393 @default.
• W4386466751 hasConcept C121608353 @default.
• W4386466751 hasConcept C126322002 @default.
• W4386466751 hasConcept C143998085 @default.
• W4386466751 hasConcept C144024400 @default.
• W4386466751 hasConcept C146357865 @default.
• W4386466751 hasConcept C151730666 @default.
• W4386466751 hasConcept C177713679 @default.
• W4386466751 hasConcept C2776256026 @default.
• W4386466751 hasConcept C2777701055 @default.
• W4386466751 hasConcept C2777863537 @default.
• W4386466751 hasConcept C2779903281 @default.
• W4386466751 hasConcept C36289849 @default.

• next